Takara Bio Inc. reported earnings results for the first quarter ended June 30, 2017. For the quarter, the company's net sales were ¥6,355 million against ¥6,306 million a year ago. Operating income was ¥262 million against ¥643 million a year ago. Ordinary income was ¥287 million against ¥653 million a year ago. Net income attributable to owners of the parent was ¥22 million against ¥285 million a year ago. Net income per share was ¥0.19 compared to ¥2.37 a year ago.

For the six months ending September 30, 2017, the company now expects net sales of ¥14,049 million, operating income of ¥487 million, ordinary income of ¥523 million, net income attributable to owners of the parent of ¥18 million or ¥0.16 per share.

For the year ending March 31, 2018, the company now expects net sales of ¥33,200 million, operating income of ¥3,300 million, ordinary income of ¥3,600 million, net income attributable to owners of the parent of ¥1,850 million or ¥15.36 per share.